Neurology Alert – May 1, 2010
May 1, 2010
View Issues
-
Repetitive Transcranial Magnetic Stimulation for Tinnitus: An Evolving Therapy
Transcranial magnetic stimulation of the brain may be a promising new therapy for the treatment of chronic tinnitus. -
New Developments in Attentional Rehabilitation
The presence of conjugate eye deviation as measured by CT or MRI in acute stroke patients predicts visuo-spatial neglect. Prismatic therapy produces a cross-modality improvement in left-sided auditory extinction in patients with chronic right-sided stroke. -
Levetiracetam in Newly Diagnosed Glioma, Epilepsy
This prospective case series reports on the efficacy and safety of levetiracetam in central nervous system gliomas. -
Prognostic Factors in a Large Cohort of Patients with Glioblastoma
This large retrospective study reports an overall poor prognosis for patients with GBM, but treatment was not "state-of-the-art." -
Spinal Sarcoidosis
Spinal cord sarcoidosis is difficult to diagnose and may be confused with multiple sclerosis and neuromyelitis optica. Treatment response is variable. -
Stroke Alert: A Review of Current Clinical Stroke Literature
Prabhakaran S, et al. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2010;67: (doi:10.1001/archneurol.2010.25). -
Supplement: Health Care Reform Update
Health care clinicians and organizations likely will find that the new health care reform bill's positive features outweigh its drawbacks, experts say. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.